FEB 12, 2017 6:46 AM PST

New Test Predicts Graft-Versus-Host Disease Outcome and Survival

WRITTEN BY: Xuan Pham

It’s tragically ironic that in medicine, sometimes the cure is almost as harmful as the poison. This is the case for bone marrow transplant, which could have the nearly same chance of saving a patient as it does harming the patient. To minimize the risks and guide the decision process, scientists at the Mount Sinai School of Medicine developed an algorithm that’s smart enough to predict the outcome of this procedure for each patient.

Dubbed the “MAGIC algorithm” (Mount Sinai Acute GVHD International Consortium algorithm), this tool measures the concentrations of the proteins ST2 and REG3A. Abnormal presence of these proteins can signal the oncoming of graft-versus-host disease (GVHD) weeks before symptoms occur. In GVHD, the patient’s body recognizes the transplanted bone marrow as foreign and begins to attack, causing life-threatening complications. Knowing if this scenario will play out should give doctors more time to react and possibly prevent full-blown GVHD cases.

"The MAGIC algorithm gives doctors a roadmap to save many lives in the future. This simple blood test can determine which bone marrow transplant patients are at high risk for a lethal complication before it occurs," said Dr. James L.M. Ferrara, Professor at the Icahn School of Medicine at Mount Sinai, and Co-director of MAGIC. "It will allow early intervention and potentially save many lives."

The algorithm was developed after analyzing nearly 1,300 bone marrow transplant samples from 11 hospital centers. With this extensive sample, the team found that presence of two key proteins predicted the likelihood of a patient developing lethal GVHD.

"This test will make bone marrow transplant safer and more effective for patients because it will guide adjustment of medications to protect against graft-versus-host disease," said Dr. John Levine, Professor at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai and Co-director of MAGIC. "If successful, the early use of the drugs would become a standard of care for bone marrow transplant patients."

Of note, a bone marrow transplant is a procedure that replaces a patient’s diseased blood stem cells with healthy ones from a matched donor. There are several conditions that warrant a bone marrow transplant. These often involve blood disorders, such as cancer of the blood (leukemia), sickle cell anemia, or thalassemia. In some instances, chemotherapy or radiation treatment can damage the bone marrow, necessitating a transplant.

Additional sources: The Mount Sinai Hospital

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUL 22, 2021
Cell & Molecular Biology
Cancer Cells in the Lab Aren't Like Cancer Cells in the Body
JUL 22, 2021
Cancer Cells in the Lab Aren't Like Cancer Cells in the Body
To study biology, researchers need models. Once those models might have been a bit limited to organisms like rats or mic ...
AUG 18, 2021
Cell & Molecular Biology
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
AUG 18, 2021
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
For many years, researchers have studied how an enzyme called APOBEC3 can help protect the body from pathogenic viruses, ...
AUG 29, 2021
Cancer
Researchers Bioprint Deadly Brain Tumor with 3D Printer
AUG 29, 2021
Researchers Bioprint Deadly Brain Tumor with 3D Printer
Researchers have managed to print an entire active and viable glioblastoma tumor- the deadliest form of brain cancer- us ...
SEP 06, 2021
Cancer
A New Biomarker to Personalize Breast Cancer Therapy
SEP 06, 2021
A New Biomarker to Personalize Breast Cancer Therapy
The American Cancer Society estimates that over 280,000 women in the United States will be diagnosed with breast cancer ...
OCT 14, 2021
Cancer
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
OCT 14, 2021
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
Colorectal cancer develops when a series of changes occur across multiple genes.  While researchers have paid signi ...
Loading Comments...